The APOLLO Trial
If you have symptomatic mitral regurgitation (MR), you may be a candidate for the APOLLO Trial.
CAUTION: The Intrepid™ transcatheter mitral valve replacement system is an investigational device. Limited by federal (United States) law to investigational use. Exclusively for clinical investigations. Not approved by FDA and not for sale in the United States.
CAUTION: Investigational device. To be used by qualified investigators only. Exclusively for clinical investigations.
What is the APOLLO Trial?
Mitral regurgitation (MR) can affect your daily quality of life. The APOLLO Trial is evaluating the safety and effectiveness of an investigative treatment for severe MR patients who may be unsuitable for approved transcatheter repair or surgery.
Are you eligible for the clinical trial?
If you have symptomatic MR and meet the study criteria, you may be eligible to participate in the APOLLO clinical trial.
Where are the clinical trial locations?
Learn if there’s a trial location near you and find contact information to learn more.
Individual results may vary.
This information is designed to help you learn more about transcatheter mitral valve replacement. It is intended to provide you with helpful information but is for information purposes only, it is not medical advice and should not be used as an alternative to speaking with your doctor. Be sure to discuss questions specific to your health and treatments with your doctor. For more information on the APOLLO Trial, please speak to your doctor and contact your local participating trial site doctor using the “Find a Location” tab.